Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-25-029842
Filing Date
2025-12-31
Accepted
2025-12-31 17:10:06
Documents
1
Period of Report
2025-12-12

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3541
  Complete submission text file 0001493152-25-029842.txt   5304
Mailing Address 17571 VON KARMAN AVENUE IRVINE CA 92614
Business Address 17571 VON KARMAN AVENUE IRVINE CA 92614 9493792875
BIOMERICA INC (Issuer) CIK: 0000073290 (see all company filings)

EIN.: 952645573 | State of Incorp.: DE | Fiscal Year End: 0531
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 17571 VON KARMAN AVE. IRVINE CA 92614
Business Address
Irani Zackary S. (Reporting) CIK: 0001282349 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37863 | Film No.: 251617942